Developer docs
API playgroundTry for free, no card

Search company profiles

LexaMed

Full company profile

uuid000iulz

Namestring
LexaMed
Legal namestring
LexaMed
Websiteurl
lexamed.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

LexaMed is a privately held contract testing laboratory headquartered in Toledo, Ohio, founded in 2006, that provides microbiology, analytical chemistry, sterilization validation, environmental monitoring, and packaging integrity testing services to medical device and pharmaceutical manufacturers. Its core offering spans Medical Device Lot Release Testing, Pharmaceutical Lot Release Testing, and Technical Consulting Services, supported by a broad menu of specialized tests including USP <71> sterility, USP <85> bacterial endotoxin, bioburden, particulate testing per USP <788>/<789>, cytotoxicity, D-value verification using BIER units, microbial stability studies, and reusable medical device cleaning/sterilization validations. The company also publishes standardized turnaround times (e.g., 7-day endotoxin, 10-day bioburden, 8–15-day sterility) and advertises a 99.99% error-free report rate, indicating a routine-testing layer alongside bespoke validation work.

The business operates as a sales-led contract laboratory, serving two primary verticals (medical device manufacturers and pharmaceutical manufacturers) with a quote-based engagement model and direct client portal access. LexaMed holds ISO 13485 certification, ISO 17025 accreditation (valid through 2027), DEA Controlled Substance registration, FDA establishment registration, and a State of Ohio Drug License, positioning it to bid on regulated testing work. The company is independently owned, with no disclosed parent company, private equity backing, or institutional investment identified in the source material.

Revenue mechanics are not publicly disclosed. With 11–50 employees, a nearly two-decade operating history, and an active service expansion cadence (routine SLAs, MSS, BIER D-value), LexaMed appears to be a stable mid-sized regional lab rather than a high-growth venture-backed operator. No funding rounds, acquisitions, leadership changes, or geographic expansions are documented in the available data.

Short descriptiontext

LexaMed is a Toledo, Ohio-based contract testing laboratory providing USP-method microbiology, sterility, endotoxin, particulate, sterilization validation, and packaging integrity testing services to medical device and pharmaceutical manufacturers, complemented by technical consulting.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToledo, United States
HQ citystring
Toledo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
contract laboratory testing, medical device testing, pharmaceutical testing services, sterilization validation, microbial testing
Industry2 codes
PRIMARYHLAAAKAG
Analytical Testing & QC Release Services (potency, purity, sterility)
SECONDARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
NAICS code1 code
  • Testing Laboratories and Services541380
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Laboratory Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

LexaMed provides contract laboratory testing services to medical device and pharmaceutical manufacturers, covering lot release testing (sterility, endotoxin, bioburden, particulates), microbiology, analytical chemistry, sterilization validations, environmental monitoring, package integrity testing, and reusable device cleaning and sterilization validations. The company complements these laboratory services with technical consulting in regulatory assistance, quality management, and compliance auditing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Reports are published 99.99% error free
Product overview1 text field

LexaMed is a contract laboratory and consulting company providing medical device and pharmaceutical manufacturers with comprehensive laboratory testing services complemented by technical consulting. The core offerings include Medical Device Lot Release Testing, Pharmaceutical Testing Services, and Technical Consulting Services. Testing services span across multiple specialized modules including Microbiology Testing, Particulate Testing, Cytotoxicity Testing, Analytical Chemistry Testing, Sterilization Validations, Environmental Monitoring, and Package Integrity Testing. Specialized studies include Microbial Stability Studies (MSS), D-value Verifications, and Reusable Medical Device Validations. The company also offers Routine Testing services for sterility, endotoxin, and bioburden with specific turnaround times. All services are supported by ISO 13485 certification and ISO 17025 accreditation.

Product and service1 record
1Medical Device Lot Release Testing
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global testing services conglomerate with extensive pharmaceutical and medical device testing capabilities across hundreds of sites; competes with LexaMed on sterility, endotoxin, and microbiological release testing but with far broader scope and scale.

TypeBroad incumbent
Description

Global TIC provider with pharmaceutical services including sterility, endotoxin, and microbiological testing as part of its wider industrial and consumer products testing business — overlaps with LexaMed on regulated lab services.

TypeBroad incumbent
Description

Major global CRO/CDMO with an established contract testing and manufacturing services business serving pharmaceutical and medical device manufacturers across release testing, microbiology, and biologics safety — overlapping with LexaMed in pharma QC testing.

TypeBroad incumbent
Description

Large China-headquartered CRO/CDMO offering laboratory testing and bioanalytical services for pharmaceutical and medical device manufacturers — competes with LexaMed for pharma QC testing work, particularly for clients with global sourcing needs.

5MicroTest Laboratories
TypeDirect peer
Description

Massachusetts-based contract testing lab focused on medical device and pharmaceutical microbiology, sterilization validation, and package integrity — closely mirrors LexaMed's niche and serves a comparable customer base.

TypeDirect peer
Description

Salt Lake City–based contract laboratory specializing in medical device and pharmaceutical microbiological and analytical testing, including sterility, endotoxin, bioburden, and packaging integrity — directly overlaps LexaMed's core service menu and customer base.

TypeBroad incumbent
Description

Large US-based testing laboratory network offering life sciences, environmental, and pharmaceutical testing services — competes with LexaMed on pharmaceutical and medical device release testing with broader geographic reach.

TypeDirect peer
Description

Massachusetts-based preclinical and medical device testing laboratory offering extractables/leachables, biocompatibility, and toxicology testing — directly comparable niche contract lab serving medical device manufacturers, now operating under Labcorp Drug Development.

TypeDirect peer
Description

California-based contract laboratory providing medical device and pharmaceutical testing including sterility, endotoxin, bioburden, cytotoxicity, and reusable device validations — directly comparable to LexaMed's USP compendial and validation portfolio.

10SGS
TypeBroad incumbent
Description

Global testing, inspection, and certification company with a life sciences vertical offering pharmaceutical and medical device testing services — competes with LexaMed for outsourced QC and validation work, though as part of a far broader portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LexaMed

Contract Laboratory Testing Serviceslexamed.com

LexaMed is a Toledo, Ohio-based contract testing laboratory providing USP-method microbiology, sterility, endotoxin, particulate, sterilization validation, and packaging integrity testing services to medical device and pharmaceutical manufacturers, complemented by technical consulting.

What LexaMed does

LexaMed is a privately held contract testing laboratory headquartered in Toledo, Ohio, founded in 2006, that provides microbiology, analytical chemistry, sterilization validation, environmental monitoring, and packaging integrity testing services to medical device and pharmaceutical manufacturers. Its core offering spans Medical Device Lot Release Testing, Pharmaceutical Lot Release Testing, and Technical Consulting Services, supported by a broad menu of specialized tests including USP <71> sterility, USP <85> bacterial endotoxin, bioburden, particulate testing per USP <788>/<789>, cytotoxicity, D-value verification using BIER units, microbial stability studies, and reusable medical device cleaning/sterilization validations. The company also publishes standardized turnaround times (e.g., 7-day endotoxin, 10-day bioburden, 8–15-day sterility) and advertises a 99.99% error-free report rate, indicating a routine-testing layer alongside bespoke validation work.

The business operates as a sales-led contract laboratory, serving two primary verticals (medical device manufacturers and pharmaceutical manufacturers) with a quote-based engagement model and direct client portal access. LexaMed holds ISO 13485 certification, ISO 17025 accreditation (valid through 2027), DEA Controlled Substance registration, FDA establishment registration, and a State of Ohio Drug License, positioning it to bid on regulated testing work. The company is independently owned, with no disclosed parent company, private equity backing, or institutional investment identified in the source material.

Revenue mechanics are not publicly disclosed. With 11–50 employees, a nearly two-decade operating history, and an active service expansion cadence (routine SLAs, MSS, BIER D-value), LexaMed appears to be a stable mid-sized regional lab rather than a high-growth venture-backed operator. No funding rounds, acquisitions, leadership changes, or geographic expansions are documented in the available data.

LexaMed firmographics

Firmographics
Name
LexaMed
Legal name
LexaMed
Website
https://lexamed.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
LexaMed is a Toledo, Ohio-based contract testing laboratory providing USP-method microbiology, sterility, endotoxin, particulate, sterilization validation, and packaging integrity testing services to medical device and pharmaceutical manufacturers, complemented by technical consulting.
Ownership category
akta.pro rank

LexaMed industry classification

Industry
Product category
Contract Laboratory Testing Services
NAICS
Testing Laboratories and Services (541380)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAAKAG
Analytical Testing & QC Release Services (potency, purity, sterility)
SECONDARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)

Keywords

  • Contract laboratory testing
  • Medical device testing
  • Pharmaceutical testing services
  • Sterilization validation
  • Microbial testing

Where LexaMed is headquartered

Location

Headquarters

HQ city
Toledo
HQ country
United States
HQ region
North America

Markets served

LexaMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

LexaMed product offering

Product offering

Core offering

LexaMed provides contract laboratory testing services to medical device and pharmaceutical manufacturers, covering lot release testing (sterility, endotoxin, bioburden, particulates), microbiology, analytical chemistry, sterilization validations, environmental monitoring, package integrity testing, and reusable device cleaning and sterilization validations. The company complements these laboratory services with technical consulting in regulatory assistance, quality management, and compliance auditing.

Product overview

LexaMed is a contract laboratory and consulting company providing medical device and pharmaceutical manufacturers with comprehensive laboratory testing services complemented by technical consulting. The core offerings include Medical Device Lot Release Testing, Pharmaceutical Testing Services, and Technical Consulting Services. Testing services span across multiple specialized modules including Microbiology Testing, Particulate Testing, Cytotoxicity Testing, Analytical Chemistry Testing, Sterilization Validations, Environmental Monitoring, and Package Integrity Testing. Specialized studies include Microbial Stability Studies (MSS), D-value Verifications, and Reusable Medical Device Validations. The company also offers Routine Testing services for sterility, endotoxin, and bioburden with specific turnaround times. All services are supported by ISO 13485 certification and ISO 17025 accreditation.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Device Lot Release Testing

Quantifiable outcome

  • Reports are published 99.99% error free

Companies that use LexaMed

Customer profile

Segments2 records

Ideal customer profiles2 records

LexaMed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

LexaMed partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

LexaMed competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global testing services conglomerate with extensive pharmaceutical and medical device testing capabilities across hundreds of sites; competes with LexaMed on sterility, endotoxin, and microbiological release testing but with far broader scope and scale.
  • Intertek: Global TIC provider with pharmaceutical services including sterility, endotoxin, and microbiological testing as part of its wider industrial and consumer products testing business — overlaps with LexaMed on regulated lab services.
  • Charles River Laboratories: Major global CRO/CDMO with an established contract testing and manufacturing services business serving pharmaceutical and medical device manufacturers across release testing, microbiology, and biologics safety — overlapping with LexaMed in pharma QC testing.
  • WuXi AppTec: Large China-headquartered CRO/CDMO offering laboratory testing and bioanalytical services for pharmaceutical and medical device manufacturers — competes with LexaMed for pharma QC testing work, particularly for clients with global sourcing needs.
  • Pace Analytical: Large US-based testing laboratory network offering life sciences, environmental, and pharmaceutical testing services — competes with LexaMed on pharmaceutical and medical device release testing with broader geographic reach.
  • SGS: Global testing, inspection, and certification company with a life sciences vertical offering pharmaceutical and medical device testing services — competes with LexaMed for outsourced QC and validation work, though as part of a far broader portfolio.

Direct peers

  • MicroTest Laboratories: Massachusetts-based contract testing lab focused on medical device and pharmaceutical microbiology, sterilization validation, and package integrity — closely mirrors LexaMed's niche and serves a comparable customer base.
  • Nelson Laboratories: Salt Lake City–based contract laboratory specializing in medical device and pharmaceutical microbiological and analytical testing, including sterility, endotoxin, bioburden, and packaging integrity — directly overlaps LexaMed's core service menu and customer base.
  • Toxikon: Massachusetts-based preclinical and medical device testing laboratory offering extractables/leachables, biocompatibility, and toxicology testing — directly comparable niche contract lab serving medical device manufacturers, now operating under Labcorp Drug Development.
  • Pacific Biolabs: California-based contract laboratory providing medical device and pharmaceutical testing including sterility, endotoxin, bioburden, cytotoxicity, and reusable device validations — directly comparable to LexaMed's USP compendial and validation portfolio.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

LexaMed social profiles

Digital presence

LexaMed compliance and trust

Trust signal

Compliance5 records

LexaMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LexaMed leadership team

Management profile

Number of profiles

LexaMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LexaMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LexaMed

What does LexaMed do?

LexaMed provides contract laboratory testing services to medical device and pharmaceutical manufacturers, covering lot release testing (sterility, endotoxin, bioburden, particulates), microbiology, analytical chemistry, sterilization validations, environmental monitoring, package integrity testing, and reusable device cleaning and sterilization validations. The company complements these laboratory services with technical consulting in regulatory assistance, quality management, and compliance auditing.

Is LexaMed a public or private company?

LexaMed is a private company. It is classified as unknown and is currently operating.

When was LexaMed founded?

LexaMed was founded in 2006. It employs 11 to 50 people.

Where is LexaMed based?

LexaMed is headquartered in Toledo, United States, in the North America region.

Who are LexaMed's main competitors?

Broad incumbents on record are Eurofins Scientific, Intertek, Charles River Laboratories, WuXi AppTec, Pace Analytical and SGS. Direct peers are MicroTest Laboratories, Nelson Laboratories, Toxikon and Pacific Biolabs.

Does LexaMed have an API?

No public API is recorded for LexaMed.

What industry is LexaMed in?

LexaMed's product category is Contract Laboratory Testing Services. Its primary akta.pro industry code is HLAAAKAG, Analytical Testing & QC Release Services (potency, purity, sterility), with a secondary code of HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility). Its NAICS code is 541380 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales